EvaluatePharma USA, Inc. Welcomed to the Massachusetts Economy

Mar 31, 2011, 01:00 ET from EvaluatePharma USA, Inc

BOSTON, March 31, 2011 /PRNewswire/ -- EvaluatePharma USA, Inc., the online analysis service for the global biotechnology and pharmaceutical sector, was welcomed into Massachusetts's economy yesterday evening, at the MassEcon Corporate Welcome Reception, held at Citizens Bank, 28 State Street, Boston, MA.

The event brought together senior state officials and private sector leaders to welcome companies that recently opened their doors in Massachusetts, and provides a forum for new companies to develop a long-term network.

Debbie Paul, Senior Vice President, North America, said "EvaluatePharma USA are very excited to be joining the Massachusetts economy with the opening of our US Headquarters in Boston. Many of our clients are based in Massachusetts, and we are now able to work more closely with them and the wider life science community to develop additional services that support the future growth of this sector. We thank the Boston Redevelopment Authority and the Massachusetts Life Sciences Center for their continued support."

New service offerings in 2011 include Partnering Opportunities, a free service that allows companies with novel drug products to post licensing opportunities alongside EvaluatePharma(R)'s unique industry analysis, including product portfolios, company financials and reference deal terms, and completely new content sets covering Clinical Trials and Venture Finance.

Commenting on the welcome from MassEcon, Dr. Jonathan de Pass, CEO and Founder said "We are very grateful to MassEcon for their welcome. EvaluatePharma is committed to developing new products and services that continue to support the life science community and their advisors in Investment Banks, Management Consultancies, and elsewhere. Our presence in Boston allows us to get so much closer to our clients, prospects and friends in Massachusetts."

Notes to editors

About MassEcon

MassEcon is a private non-profit partnership of business, industry, and government leaders dedicated to fostering growth in the Commonwealth. Launched in 1993 by the Governor's Council for Growth and Technology, MassEcon promotes Massachusetts by providing information services to companies seeking to expand or relocate to the state. MassEcon's services include the Site Finder Service, the Research & Information Service, and the Massachusetts Ambassadors program. MassEcon is a member of the Massachusetts Business Resource Team.

About EvaluatePharma:

EvaluatePharma USA, Inc. is the representative in North America of EvaluatePharma Ltd, the UK-based publisher of EvaluatePharma(R).

The research company EvaluatePharma Ltd was the first to supply reliable consensus forecasts of global drug sales and now provides standardised worldwide financial and forecast models with consensus product sales forecasts to 2016, data on R&D pipelines, licensing deals, patent risk and M&A activity. Launched in 2007, EvaluatePharma(R) Alpha offers a Net Present Value (NPV) valuation service quantifying market events and the impact on product, portfolio and company valuation including the daily online news service EP Vantage(R).

EvaluatePharma(R), EvaluatePharma(R)Alpha, and EP Vantage(R) are services of EvaluatePharma Ltd, headquartered in London, England.

    http://www.evaluatepharma.com

    Contact:

    Debbie Paul
    Senior Vice President, North America
    T: +1-617-573-9453
    E: debbiep@evaluatepharma.com

    EvaluatePharma USA, Inc.
    15 Broad Street, Suite 401
    Boston, MA 02109
    USA

    Andrew Beaven
    Marketing Director, EvaluatePharma Ltd
    T: +44(0)20-7377-0800
    E: andrewb@evaluatepharma.com

    EvaluatePharma Ltd
    11-29 Fashion Street
    LONDON E1 6PX
    United Kingdom


SOURCE EvaluatePharma USA, Inc